Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

1.89
Delayed Data
As of 10:14am ET
 +0.0185 / +0.99%
Today’s Change
1.79
Today|||52-Week Range
5.35
-9.64%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close1.87
Today’s open1.89
Day’s range1.88 - 1.89
Volume1,996
Average volume (3 months)36,203
Market cap$32.1M
Dividend yield--
Data as of 10:14am ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)+42.50%
Earnings growth (this year)-4.75%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book0.96

Competitors

 Today’s
change
Today’s
% change
SBOTStellar Biotechnolog...+0.07+1.83%
CBLICleveland Biolabs In...0.000.00%
EBIOEleven Biotherapeuti...+0.13+7.79%
CTRVContraVir Pharmaceut...+0.11+10.40%
Data as of 10:20am ET, 07/01/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$5.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
James Garner
Chief Financial Officer
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts

Partner Offers

Search for Jobs